Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Close this folder7. The editorial process
View the document7.1 Outline of the editorial process
Close this folder7.2 Editing a drug bulletin
View the document7.2.1 Editorial independence
View the document7.2.2 Strong and sustained editorial policy and a committed team
View the document7.2.3 Selecting topics for articles
View the document7.2.4 Using and adapting existing material
View the document7.2.5 Planning a bulletin issue
Open this folder and view contents7.3 Writing bulletin articles
Open this folder and view contents7.4 Reviewing the article
View the document7.5. Rewriting the article
View the document7.6 Final checks
Open this folder and view contents7.7 Follow-up after publication
View the document7.8 References
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

7.2.1 Editorial independence

Producing good quality articles implies:

• the ability to choose useful topics with total freedom according to the readers’ needs, keeping in mind that these needs may differ at times from an editor’s wishes, and;

• the freedom to put patients’ interests first, and not to follow a political, industrial or any other agenda that is unrelated to patients’ interests;

• access to all useful scientific data, and the freedom to fight for access if necessary;

• the freedom to tell the truth, without any political, economic, commercial or administrative pressure;

• the freedom to respond to criticism and to denounce false claims or statements.

This can be achieved only by people who have total editorial independence. The international WHO meeting on drug information, held in Madrid in 1985 defined independent editors as “having no commercial or other interest in the promotion of particular patterns of drug treatment, their sole aim being to optimise such treatment in the interests of the patient and society at large”.1 The organizational structure and financial resources of the bulletin should be capable of guaranteeing the editorial team's independence.2

Financial independence also creates sustainability, as discussed in Chapter 5. The editorial team and bulletin may become fragile if they are too dependent on sponsors who may decide at any time to end their support. However, if a bulletin has the support of a strong network of contacts, this may prevent sudden interruption of sponsorship.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017